About Sugen Life Sciences
Sugen Life Sciences is a company based in Tirupati (India) founded in 2005. Sugen Life Sciences offers products and services including Toxicology Services, Pharmacology Services, Genotoxicology Services, and PDE Determinations. Sugen Life Sciences operates in a competitive market with competitors including GenOway, TransCure bioServices, InVivo Biosystems, PsychoGenics and PharmaLegacy Laboratories, among others.
- Headquarter Tirupati, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sugen Life Sciences Private Limited
- Date of Incorporation 20 Apr, 2005
- Jurisdiction Tirupathi, Andhra Pradesh, India
-
Annual Revenue
$361.1 K (USD)-8.17as on Mar 31, 2023
-
Net Profit
$25.88 K (USD)-35.64as on Mar 31, 2023
-
EBITDA
$94.62 K (USD)-0.69as on Mar 31, 2023
-
Latest Funding Round
$90.73 K (USD), Grant
May 19, 2010
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sugen Life Sciences
Sugen Life Sciences offers a comprehensive portfolio of products and services, including Toxicology Services, Pharmacology Services, Genotoxicology Services, and PDE Determinations.
Conducts toxicology studies to assess drug safety and compliance.
Performs assays for drug candidate development and effectiveness.
Evaluates genotoxic impurities in pharmaceutical products.
Determines permitted daily exposure limits for medicinal products.
Funding Insights of Sugen Life Sciences
Investors in Sugen Life Sciences
Sugen Life Sciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Department of Biotechnology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotechnology research, guidelines, and funding by the Government of India.
|
Locked | Locked | Locked |
Investor details for Sugen Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sugen Life Sciences
Investment portfolio details for Sugen Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sugen Life Sciences
Detailed financials for Sugen Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sugen Life Sciences Comparisons
Peer comparison for Sugen Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sugen Life Sciences
Sugen Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenOway, TransCure bioServices, InVivo Biosystems, PsychoGenics and PharmaLegacy Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| Locked | Locked | Locked |
Humanized mouse models are developed for preclinical immune drug studies.
|
|
| Locked | Locked | Locked |
Animal models are supplied for in-vivo analytical services.
|
|
| Locked | Locked | Locked |
Preclinical CRO services for CNS and orphan disorders are offered.
|
|
| Locked | Locked | Locked |
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
|
|
| Locked | Locked | Locked |
Preclinical contract research organization offering standard GLP and non-GLP services
|
Detailed competitors of Sugen Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sugen Life Sciences
Complete news archive for Sugen Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sugen Life Sciences
Sugen Life Sciences was founded in 2005 and raised its 1st funding round 5 years after it was founded.
Sugen Life Sciences is headquartered in Tirupati, India. It is registered at Tirupati, Andhra Pradesh, India.
Annual revenue of Sugen Life Sciences is $361.1K as on Mar 31, 2023.
Sugen Life Sciences (SLS) is a CRO with prime focus on pre-clinical safety, efficacy toxicology testing and services to biopharma industries. They also offer clinical development services such as protocol design, investigator and site selection, data management and regulatory compliance services for clinical trials from phases II to IV. Its toxicology services include acute testing in animal models, mutagenicity; pharmacology services in diabetes, inflammation and lung fibrosis. It also has an RD unit working in the areas of diabetes, wound healing and cancer. Besides, it also supplies phytochemicals.
Sugen Life Sciences's top competitors include GenOway, PsychoGenics and PharmaLegacy Laboratories.
Sugen Life Sciences offers Toxicology Services, Pharmacology Services, Genotoxicology Services, and PDE Determinations.
Sugen Life Sciences has 1 investor. Key investors include Department of Biotechnology.